Target intelligence / Profile preview

NAD-dependent protein deacylase sirtuin-6 (SIRT6)

Target
SIRT6
Molecular classification
Enzyme, Histone deacetylase, Mono-ADP-ribosyltransferase, DNA repair factor, Sirtuin family
01

Overview

**NAD-dependent protein deacylase sirtuin-6 (SIRT6)** is an evolutionarily conserved enzyme belonging to the sirtuin family, characterized by its dependence on NAD(^+) as a cofactor for catalysis[1][2][4]. SIRT6 acts primarily as a histone deacetylase, most notably removing acetyl groups from histones H3 and H4, thereby regulating chromatin structure and gene expression[4][2]. It also possesses mono-ADP-ribosyltransferase activity, participating in the repair of DNA double-strand breaks by recruiting repair proteins and modulating poly(ADP-ribose) polymerase (PARP1) activity[3][4]. SIRT6 is crucial for cellular responses to genotoxic stress, genomic stability, DNA repair capacity, metabolic homeostasis, and lifespan regulation[3][4][5]. It interacts with small molecule modulators such as quercetin and cyanidin, which can activate or inhibit specific enzymatic activities[5][4]. SIRT6's functions make it a target of interest in cancer, metabolic, neurodegenerative, and aging-associated diseases, though broad sirtuin inhibition may threaten genomic integrity and cellular homeostasis[4][5].

Other names
Sirtuin 6SIRT6Sirt6NAD-dependent protein deacetylase sirtuin-6
02

Mechanism of action

Activation of SIRT6 deacetylation by allosteric modulation (e.g., by quercetin, cyanidin, SP-624) - Stimulation or inhibition of deacetylation and deacylation activities - Modulation of mono-ADP-ribosylation

03

Biological functions

Histone deacetylation (H3, H4)Chromatin remodelingRegulation of gene expressionDNA double-strand break (DSB) repairBase excision repairMetabolic regulationRegulation of lifespanStress response
04

Disease associations

CancerAging and age-related diseasesNeurodegenerative diseaseInflammationMetabolic disorders (e.g., diabetes)Cardiovascular disease
05

Safety considerations

Potential effects on genomic stability if inhibitedModulation of DNA repair efficiency may influence cancer risk and agingTargeting broad chromatin-modifying enzymes may risk off-target effects or impact other sirtuin family members
06

Interacting drugs

Quercetin

5 more in the full profile.

07

Biomarkers

SIRT6 expression or activity level as a biomarker for aging, genomic stability, some cancers, and inflammation

Beyond the preview

Go deeper on NAD-dependent protein deacylase sirtuin-6 (SIRT6).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NAD-dependent protein deacylase sirtuin-6 (SIRT6).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call